Articles From: Idera to Present at the Cowen & Co. 34th Annual Health Care Conference to IDT Announces Industry’s First 16-lane, 8 GT/s PCI Express 3.0 Signal-conditioning Retimer


2014/2/26
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that Company management will present at the Cowen & Co.
Sign-up for Idera to Present at the Cowen & Co. 34th Annual Health Care Conference investment picks
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the Company will be presenting at the Stifel Nicolaus 2013 Healthcare Conference.
Sign-up for Idera to Present at the Stifel Nicolaus 2013 Healthcare Conference investment picks
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today will provide a further update on its autoimmune program, and its plans for initiating clinical development in genetically defined forms of B-cell lymphoma, in a presentation at the Stifel Nicolaus 2013 Healthcare Conference in Boston.
Sign-up for Idera to Provide Update on Programs at Stifel Nicolaus Healthcare Conference investment picks
2014/2/12
As Android development continues to surge in popularity and the expectations for multi-touch interactivity becomes the norm for commercial applications, developing a high-performance Android OS solution for large-format, multi-touch devices, such as touch tables, kiosks and wall displays, has become increasingly important.
Sign-up for Ideum and 3M Collaborate to Enable High-Performance Android OS for 3M Multi-Touch Displays investment picks
IDEX Corporation (NYSE: IEX) today announced its Board of Directors has approved an additional share repurchase authorization of up to $300 million of IDEX's outstanding common shares.
Sign-up for IDEX Corporation Announces Additional Share Repurchase Authorization investment picks
2013/9/24
IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.23 per common share.
Sign-up for IDEX Corporation Declares Regular Quarterly Cash Dividend investment picks
2013/12/3
IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.23 per common share.
Sign-up for IDEX Corporation Declares Regular Quarterly Cash Dividend investment picks
2014/4/8
IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a twenty two percent increase in the company’s regular quarterly cash dividend to $0.28 per common share.
Sign-up for IDEX Corporation Increases Regular Quarterly Cash Dividend Twenty Two Percent investment picks
2014/3/20
IDEX CORPORATION (NYSE: IEX) announced today that it has scheduled the broadcast of the company’s first quarter earnings conference call over the Internet on Wednesday, April 23 rd at 9:30 a.m. CT.
Sign-up for IDEX Corporation to Webcast First Quarter 2014 Earnings Call investment picks
IDEX CORPORATION (NYSE: IEX) announced today that it has scheduled the broadcast of the company’s fourth quarter earnings conference call over the Internet on Thursday, January 30, 2014 at 9:30 a.m. CT.
Sign-up for IDEX Corporation to Webcast Fourth Quarter 2013 Earnings Call investment picks
IDEX CORPORATION (NYSE: IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Tuesday, October 22, 2013 at 9:30 a.m. CT.
Sign-up for IDEX Corporation to Webcast Third Quarter 2013 Earnings Call investment picks
2014/1/29
IDEX Corporation (NYSE: IEX) today announced its financial results for the three- and twelve- month periods ended December 31, 2013.
Sign-up for IDEX Reports 15 Percent EPS Growth and 28 Percent Free Cash Flow Growth in 2013; Q4 EPS of 82 Cents Driven by 20 Percent Operating Margin investment picks
IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended September 30, 2013.
Sign-up for IDEX Reports Record Third Quarter Results - EPS of 78 Cents and Free Cash Flow of $113 Million investment picks
WESTBROOK, Maine , Aug.
Sign-up for IDEXX Laboratories Acquires Brazil Distributor investment picks
2014/2/4
- Delivers fourth quarter organic growth of 10.6%, driven by strong companion animal recurring revenue and instrument placements - Reports full year EPS of $3.48 at high end of Company guidance - Reaffirms outlook for higher organic revenue growth in 2014 WESTBROOK, Maine , Feb.
Sign-up for IDEXX Laboratories Announces Fourth Quarter and Full-Year Financial Results investment picks
WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories Announces Third Quarter Results investment picks
2014/3/11
WESTBROOK, Maine , March 11, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) , today announced the unanimous election of Daniel M.
Sign-up for IDEXX Laboratories Elects Daniel Junius to Board of Directors investment picks
2014/1/13
Advanced technology expands the leading line of IDEXX point-of-care analyzers and combines a full chemistry panel with electrolytes and total T4 (thyroxine) into a single sample run to deliver unprecedented diagnostic insight WESTBROOK, Maine , Jan.
Sign-up for IDEXX Laboratories Introduces the Catalyst One™ Chemistry Analyzer investment picks
WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories Names Brian McKeon Executive Vice President and Chief Financial Officer investment picks
WESTBROOK, Maine , Jan.
Sign-up for IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference investment picks
WESTBROOK, Maine , Nov.
Sign-up for IDEXX Laboratories to Present at Piper Jaffray 25th Annual Healthcare Conference investment picks
2014/2/25
WESTBROOK, Maine , Feb.
Sign-up for IDEXX Laboratories to Present at Raymond James 35th Annual Institutional Investors Conference investment picks
2014/1/23
WESTBROOK, Maine , Jan.
Sign-up for IDEXX Laboratories to Release 2013 Fourth Quarter and Full-Year Financial Results investment picks
2013/10/9
WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories to Release 2013 Third Quarter Financial Results investment picks
Patients encouraged to embrace digital advances which allow "networking to a degree that previously might not have been possible" BRISBANE, Calif.
Sign-up for Idiopathic pulmonary fibrosis (IPF) community emphasizes the power of united support for patients during IPF World Week 2013 investment picks
2014/2/11
Maxwell's Engine Start Module Provides Cranking Power for Reliable All-Weather Starting SAN DIEGO , Feb.
Sign-up for Idle Free Systems Designs Maxwell Technologies Ultracapacitor Module Into New Anti-Idling System for Snow Plows, Municipal, Utility and Other Work Trucks investment picks
2013/10/7
http://media.marketwire.com/attachments/201309/183678_idslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1057119&ProfileId=051205&sourceType=1 LAKE ELSINORE, CA --
Sign-up for IDS Industries Provides Details for Upcoming Investor Conference Call investment picks
http://media.marketwire.com/attachments/201309/183678_idslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1054418&ProfileId=051205&sourceType=1 LAKE ELSINORE, CA --
Sign-up for IDS Industries Schedules Investor Update and Conference Call investment picks
Integrated Device Technology, Inc. (IDT ® or the Company) (NASDAQ: IDTI) , the Analog and Digital Company™ delivering essential mixed-signal semiconductor solutions, today announced that Richard D.
Sign-up for IDT Announces Departure of Chief Financial Officer investment picks
2013/9/10
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ: IDTI) , the Analog and Digital Company™ delivering essential mixed-signal semiconductor solutions, today announced the industry’s first 16-lane PCI Express ® 3.0 signal-conditioning retimer .
Sign-up for IDT Announces Industry’s First 16-lane, 8 GT/s PCI Express 3.0 Signal-conditioning Retimer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Idera to Present at the Cowen & Co. 34th Annual Health Care Conference to IDT Announces Industry’s First 16-lane, 8 GT/s PCI Express 3.0 Signal-conditioning Retimer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity